CIK 0001377121 · Large accelerated filer
Protagonist Therapeutics, Inc
Sign in to watch- Ticker
- PTGX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980505495
- Phone
- (510) 474-0170
- Business address
- 7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
- Former names
- Protagonist Therapeutics Inc, Protagonist Inc
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 4 Open-market sale Chief Medical Officer sold 2,017 shares at $19.00 ($38,323)
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- 4 Open-market sale Chief Medical Officer sold 3,687 shares at $14.31 ($52,753)
- S-3 Offering Registration Statement
- CT ORDER Other Confidential Order
- 4 Open-market sale Chief Medical Officer sold 1,512 shares at $17.00 ($25,704)
- 4 Open-market sale Chief Scientific Officer sold 3,500 shares at $15.00 ($52,500)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K/A Event Exhibits
- 4 Open-market sale Chief Scientific Officer sold 3,500 shares at $12.68 ($44,380)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 3 Insider Initial Statement of Ownership
Page 31 of 36 · 707 filings